Johnson & Johnson
Market cap $664.9B
$276.22
JNJ
$276.22
+1.43% today
Buy with €1M virtual cash · No real money
Johnson & Johnson (JNJ) is a publicly traded company listed on the XNYS. As of November 8, 2026, Invest's signal rates JNJ a Buy, with the stock up 49% over the past year. You can practice trading JNJ risk-free with €1,000,000 in virtual cash.
Key stats
As of November 8, 2026
Market Cap
$664.9B
Volume
8.9M
52-wk High
$282.02
52-wk Low
$185.12
Day High
$276.41
Day Low
$265.55
Performance
1M
+7.7%
6M
+24.8%
1Y
+48.5%
Invest signal · JNJ
BuyAlgorithmic signal from price trend, valuation, and fundamentals — educational only, not financial advice.
JNJ overview
AI overviewLatest JNJ news
Choosing Healthcare ETFs: Why IHE Outperforms IBB for Many Investors
The Motley Fool · 21h ago
The Healthcare ETF Showdown: Broad Global Health or Targeted Pharma Power?
The Motley Fool · 23h ago
Breakfast News: Stocks That Let You Sleep at Night
The Motley Fool · 1d ago
If Stocks Tumble This Winter, History Says Investors Who Make This 1 Move Come Out Ahead
The Motley Fool · 1d ago
Hims & Hers Health vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy for 2027?
The Motley Fool · 1d ago
About Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023.
After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Employees
140,800
How to practice trading JNJ
- 1
Use the JNJ buy panel above
Set a quantity and hit Buy at the real market price — right here, nothing to download.
- 2
Trade with €1,000,000 virtual cash
You get a million in virtual money instantly to invest, risk-free.
- 3
Create a free account to save it
Sign up in seconds to keep your portfolio and track its performance.
- 4
Track and compete
Watch your portfolio grow and climb the global leaderboard — or start a private league.
- 5
Prefer mobile? Get the iOS app
Invest is also free on the App Store, synced with your web account.
Top JNJ traders on Invest
Full leaderboardFrequently asked questions
Is JNJ a good stock to buy right now?
As of November 8, 2026, Invest's signal rates JNJ a Buy, based on its price trend, valuation, and fundamentals, with the stock up 49% over the past year. This is an educational signal, not financial advice — the best way to test the thesis is to practice trading JNJ risk-free first.
What is Johnson & Johnson's (JNJ) market cap?
Johnson & Johnson has a market capitalization of approximately $664.9B.
How has JNJ stock performed?
JNJ is up 49% over the past year and up 25% over six months. Its 52-week range runs roughly from $185.12 to $282.02. Past performance doesn't predict future results.
How can I practice trading JNJ for free?
On Invest you get €1,000,000 in virtual cash and can buy JNJ at real market prices right in your browser — no download and no real money at risk. Create a free account to save your portfolio and track its performance over time.
More stocks to practice
Designs the iPhone, Mac, and a huge services ecosystem.
Windows, Office, Azure cloud, and enterprise software.
The leading designer of AI and gaming GPUs.
E-commerce giant and the largest cloud provider (AWS).
Google Search, YouTube, Android, and cloud.
Facebook, Instagram, WhatsApp, and the metaverse.
Compare JNJ with peers